IQVIA™ Real-World Insights Bibliography

Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy
Author(s): Colombo GL, Heiman F, Peduto I
Affiliations(s): Colombo GL: CEFAT - Department of Drug Sciences, University of Pavia, Pavia, Italy. Peduto I, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy,
Publication(s):  Ther Clin Risk Manag. 2021 Apr 21;17:345-356. doi: 10.2147/TCRM.S301005
Document Type(s): Article,
Countries: Italy,
Click here for the abstract
C:
Y:
Health economics, Overactive bladder,
2021
  L:
A:
English
Clinical setting: Primary care, Cost of illness,
  Add to report
 
 
Impact of lurasidone and other antipsychotics on body weight: real-world, retrospective, comparative study of 15,323 adults with schizophrenia
Author(s): Pochiero I, Calisti F, Comandini A, Del Vecchio A, Costamagna I, Rosignoli MT, Cattaneo A, Nunna S, Peduto I, Heiman F, Chang H, Chen C, Correll C
Affiliations(s): Pochiero I: Angelini Regulatory, Research & Development, Angelini Pharma S.p.A., Rome, Italy; Peduto I and Heiman F: IQVIA Solutions Italy Srl, RWS
Publication(s):  Int J Gen Med. 2021 Jul 31;14:4081-4094. doi: 10.2147/IJGM.S320611. PMID: 34366678; PMCID: PMC8336993.
Document Type(s): Article,
Countries: Italy, USA,
Click here for the abstract
C:
Y:
Mental health, Metabolic Disorders ,
2021
  L:
A:
English
Clinical setting: Primary care, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Analisi di impatto sul budget sanitario italiano di gilteritinib per il trattamento della leucemia mieloide acuta FLT3+ recidivante o refrattaria
Author(s): Fiorentino F, La Malfa P, Di Rienzo P
Affiliations(s): Fiorentino F: IQVIA Solutions Italy Srl, RWS
Publication(s):  GIHTAD (2021) 14:4
Document Type(s): Article,
Countries: Italy,
Click here for the abstract
C:
Y:
Health economics, Oncology,
2021
  L:
A:
Italian
Budget impact, clinical setting: Secondary care,
  Add to report
 
 
First Italian guidelines for the economic evaluation of health technologies: how do they compare to NICE standards?
Author(s): Fiorentino F, Urbinati D
Affiliations(s): Fiorentino F: IQVIA Solutions Italy Srl, RWS
Publication(s):  GIHTAD (2021) 14:5
Document Type(s): Letter,
Countries: Italy,
Click here for the abstract
C:
Y:
Health policy,
2021
  L:
A:
English
Public Health,
  Add to report
 
 
Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
Author(s): Mennini FS, Gori M, Vlachaki I, Fiorentino F, La Malfa P, Urbinati D, Andreoni M
Affiliations(s): Mennini FS: EEHTA CEIS, Faculty of Economics, University of Rome "Tor Vergata", Rome, Italy; Fiorentino F, La Malfa P, Urbinati D: IQVIA Solutions Italy Srl, RWS
Publication(s):  Health Econ Rev. 2021 Oct 30;11(1):42. doi: 10.1186/s13561-021-00341-z. PMID: 34716794; PMCID: PMC8557067.
Document Type(s): Article,
Countries: Italy,
Click here for the abstract
C:
Y:
Respiratory disease,
2021
  L:
A:
English
clinical setting: Secondary care, Cost effectiveness,
  Add to report
 
 
An Italian individual-level data study investigating on the association between air pollution exposure and Covid-19 severity in primary-care setting
Author(s): Pegoraro V, Heiman F, Levante A, Urbinati D, Peduto I
Affiliations(s): Pegoraro V, Heiman F, Levante A, Urbinati D, Peduto I: IQVIA Solutions Italy S.r.l., Milan, Italy,
Publication(s):  BMC Public Health. 2021 May 12;21(1):902. doi: 10.1186/s12889-021-10949-9
Document Type(s): Article,
Countries: Italy,
Click here for the abstract
C:
Y:
Infectious disease, Public Health,
2021
  L:
A:
English
Clinical setting: Primary care, Epidemiological study, Public Health,
  Add to report
 
 
The Burden of Short-Acting ? 2-Agonist Use in Asthma: Is There an Italian Case? An Update from SABINA Program
Author(s): Di Marco F, D'Amato M, Lombardo FP, Micheletto C, Heiman F, Pegoraro V, Boarino S, Manna F, Mastromauro F, Spennato S, Papi A
Affiliations(s): Di Marco F: Department of Health Sciences, University of Milan, Respiratory Unit, ASST Papa Giovanni XXIII, Bergamo, Italy. Pegoraro V, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy,
Publication(s):  Adv Ther. 2021 May 27. doi: 10.1007/s12325-021-01772-0
Document Type(s): Article,
Countries: Italy,
Click here for the abstract
C:
Y:
Respiratory disease,
2021
  L:
A:
English
Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis,
  Add to report
 
 
Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy
Author(s): Colombo GL, Heiman F, Peduto I
Affiliations(s): Colombo GL: CEFAT - Department of Drug Sciences, University of Pavia, Pavia, Italy. Peduto I, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy,
Publication(s):  Ther Clin Risk Manag. 2021 Apr 21;17:345-356. doi: 10.2147/TCRM.S301005
Document Type(s): Article,
Countries: Italy,
Click here for the abstract
C:
Y:
Health economics, Orthopedics,
2021
  L:
A:
English
Clinical setting: Primary care, Cost of illness, Retrospective database analysis,
  Add to report
 
 
Office-based Approach to Urinary Tract Infections in 50 000 Patients: Results From the REWIND Study
Author(s): Cai T, Palagin I, Brunelli R, Cipelli R, Pellini E, Truzzi JC, Van Bruwaene S
Affiliations(s): Cai T: Department of Urology, Santa Chiara Regional Hospital, Trento, Italy. Cipelli: Obs Studies Consultat, IQVIA, RWS, Milan, Italy.
Publication(s): 
Document Type(s): Article,
Countries: Belgium, Brazil, Italy, Russian Federation,
Click here for the abstract
C:
Y:
Miscellaneous,
2021
  L:
A:
English
clinical setting: Secondary care, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Author(s): Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publication(s):  IPVC, Barcelona, Spain, 23-27 March 2020
Document Type(s): Oral presentation,
Countries: China, France, Germany, Italy, Japan, Portugal, Spain,
C:
Y:
Infectious disease, Oncology,
2020
  L:
A:
English
Burden of illness, Observational study, Retrospective Field Study,
  Add to report
 
 
 1 of 30 Next Page Last Page